資本準備金、社債発行費、売上高他1件
- 【期間】
| 年度 | 資本準備金 | 社債発行費 | 売上高 | 研究開発費 - ライフサイエンス |
|---|
| 2007/03 | 44.1億 | | - | | - | | - | |
| 2008/03 | 44.1億 | ±0% | - | | 489億 | | - | |
| 2009/03 | 44.1億 | ±0% | - | | 465億 | -4.8% | - | |
| 2010/03 | 44.1億 | ±0% | - | | 444億 | -4.7% | - | |
| 2011/03 | 49億 | +11.1% | - | | 512億 | +15.5% | - | |
| 2012/03 | 49億 | ±0% | - | | 562億 | +9.8% | - | |
| 2013/03 | 49億 | ±0% | - | | 518億 | -7.8% | - | |
| 2014/03 | 49億 | -0% | - | | 546億 | +5.3% | - | |
| 2015/03 | 66.6億 | +35.8% | - | | 556億 | +1.8% | - | |
| 2016/03 | 66.6億 | ±0% | - | | 528億 | -5.1% | - | |
| 2017/03 | 66.6億 | ±0% | - | | 523億 | -1% | - | |
| 2018/03 | 66.6億 | ±0% | - | | 570億 | +9% | - | |
| 2019/03 | 66.6億 | ±0% | - | | 596億 | +4.6% | - | |
| 2020/03 | 66.6億 | ±0% | 138百万 | | 615億 | +3.2% | 151百万 | |
| 2021/03 | 66.6億 | ±0% | - | | 591億 | -3.8% | 180百万 | +19.2% |
| 2022/03 | 66.6億 | ±0% | - | | 627億 | +6% | 240百万 | +33.3% |
| 2023/03 | 66.6億 | ±0% | - | | 651億 | +3.8% | 283百万 | +17.9% |
| 2024/03 | 66.6億 | ±0% | - | | 631億 | -3% | 529百万 | +86.9% |
